Lyophilized Injectable Market Hit US$ 5 billion by 2030


The lyophilized injectable market size is expected to reach around US$ 5 billion by 2030 from at US$ 2.7 bn in 2020, expanding growth at a CAGR of 5.1% from 2021 to 2030.

Lyophilized Injectable Market (By Type of Packaging: Single-use Vials, Point-of-care Reconstitution, Specialty Packaging; By Type of Delivery: Prefilled Diluent Syringes, Proprietary Reconstitution Devices, Single-step Devices, Multi-step Devices; By Indication; By End User) – Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2021-2030

Get Sample Copy of This Report (Including TOC, List of Tables & Figures, and Chart)@

Lyophilization is the most commonly used method for the manufacturing of parenteral pharmaceutical products, when the product is unstable in aqueous solution. It is central to the protection of materials, which require low moisture content (less than 1%) in order to ensure stability and require a sterile and gentle preservation process.

Improved quality and shelf life of lyophilized drugs has attracted industry experts to implement lyophilization in their manufacturing processes. Contract research and manufacturing organizations have increased the use of lyophilized injectable drugs to provide quality products to customers. Therefore, rapidly growing contract research manufacturing services (CRAMS) is projected to drive the global lyophilized injectable market.

Lyophilized injectable drugs are stable at ambient temperatures and only require simple rehydration to be ready to use. This removes many sources of pipetting errors, while streamlining and simplifying workflows.

Elimination of the cold chain minimizes costs and carbon footprint, and provides a positive environmental impact by minimizing the need of expanded polystyrene (EPS or ‘Styrofoam’) containers often utilized to ship temperature-controlled products.

Lyophilized products are considered safe for use, while delivering the desired functionality compared to non-lyophilized products. Moreover, lyophilization helps retain the biological and chemical activity of the chemical compound in the final product. This drives the demand for lyophilized injectable drugs in the pharmaceutical and biotechnology industries.

Expansion of Pipeline of Lyophilized Injectable Drugs to Drive Global Market

The continuous research & development to develop innovative drugs for the treatment of chronic diseases has propelled the development of lyophilized injectable drugs in the pharmaceutical industry. Product innovation and acquisition provide key players with the opportunities to penetrate a new therapeutic area/market. About 2,400 injectable products are presently in the development pipeline. This is expected to augment the global lyophilized injectable market.

Development of Alternative Methods to Hamper Market Growth

Lyophilization of injectable drugs is an expensive process. Hence, manufacturers strive to develop alternative drying methods to increase the shelf life of products, which can prove economical. However, such alternative processes need improvement in terms of retaining stability and biological or chemical activity of the substance. Roche has developed a precipitation method as an alternative to lyophilization for the production of peptides, which enabled the company to reduce production costs, and deliver an effective, quality, and affordable product to customers. The advent of alternative methods during the forecast period is likely to hamper the growth of the global lyophilized injectable market.

Single-use Vials Dominated Global Market

The report offers detailed segmentation of the global lyophilized injectable market based on type of packaging, type of delivery, indication, and end user. In terms of type of packaging, the single-use vials segment dominated the global market in 2020. The increase in self-administration of lyophilized injectable drugs to treat various chronic conditions such as diabetes, rheumatoid arthritis, and migraine is projected to drive the single-use vials segment during the forecast period. The specialty packaging segment is expected to grow at a rapid pace from 2021 to 2031, as the segment offers packaging solutions such as pens, needle-free injectors, and two-part syringes that allow reconstitution in the device prior to injection.

Hospitals to be Major End User

In terms of end user, the lyophilized injectable market has been divided into hospitals, ambulatory surgical centers, specialty clinics, and others The hospitals segment is expected to expand at a high CAGR during the forecast period, due to increase in the number of hospitals and high patient preference to visit hospitals for treatment.

North America to Dominate Global Market

The global lyophilized injectable market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global lyophilized injectable market in 2020, followed by Europe. North America accounted for a major share of the global lyophilized injectable market in 2020, due to extensive research & development activities, rapid acceptance of innovative technologies, and significant investments toward the development of healthcare infrastructure. Additionally, presence of a large number of manufacturing facilities in North America makes it the largest market for lyophilized injectable drugs.

Competitive Landscape and Market Share Analysis

The lyophilized injectable market competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, lyophilized injectable sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2017-2020, this study provides the lyophilized injectable sales, revenue and market share for each player covered in this report.

  • Crucial data regarding the major contenders, product portfolio, market remuneration, and production patterns are documented in the report.
  • The report presents the pricing models followed by each company, alongside the gross margins and market share held by each company.

The report also presents profiles of leading players in the global lyophilized injectable market. These include B. Braun Melsungen AG, Baxter International, Inc., BD, Schott AG, Aristopharma Ltd., Vetter Pharma, and Jubilant HollisterStier LLC.

Market Segmentation

Market By Type of Packaging

    • Single-use Vials
    • Point-of-care Reconstitution
    • Specialty Packaging

Market By Type of Delivery

    • Prefilled Diluent Syringes
    • Proprietary Reconstitution Devices
    • Single-step Devices
    • Multi-step Devices

Market By Indication

    • Autoimmune Diseases
    • Metabolic Conditions
    • Infectious Diseases
    • Others

Market By End User

    • Hospitals
    • Ambulatory Surgical Centers
    • Specialty Clinics
    • Others

Market By Region

    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Australia & New Zealand
      • Rest of Asia Pacific
    • Latin America
      • Brazil
      • Mexico
      • Rest of Latin America
    • Middle East & Africa
      • GCC Countries
      • South Africa
      • Rest of Middle East & Africa

The study objectives of this report are:

  • To analyze and study the global market capacity, production, value, consumption, status (2017-2021) and forecast (2021-2030);
  • Focuses on the key manufacturers, to study the capacity, production, value, market share and development plans in future.
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • To define, describe and forecast the market by type, application and region.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends and factors driving or inhibiting the market growth.
  • To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
  • To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
  • To strategically profile the key players and comprehensively analyze their growth strategies.

Buy This Premium Research Report, click here@ or call: +1 9197 992 333


Daksh is an SEO Analyst having 3 years of experienced. we can quickly understand and support initiatives that will contribute to the goals and success of client campaigns. and also Perform keyword research in coordination with client business objectives to optimize existing content and uncover new opportunities.

View all posts by Daksh →

Leave a Reply

Your email address will not be published. Required fields are marked *